Skip to content
Neuro-ophthalmology

Neuro-ophthalmologic signs of chronic basilar artery occlusion

1. What are the neuro-ophthalmologic signs of chronic basilar artery occlusion?

Section titled “1. What are the neuro-ophthalmologic signs of chronic basilar artery occlusion?”

Chronic basilar artery occlusion (CBAO) refers to long-term occlusion of the basilar artery. As the occlusion becomes chronic, collateral circulation develops, reducing the high mortality and morbidity associated with acute basilar artery occlusion.

The clinical presentation of CBAO includes the following three patterns.

  • Incidental finding: Discovered incidentally on angiography.
  • Symptomatic, non-infarct type: Vertebrobasilar symptoms are present but without brainstem infarction.
  • Acute-to-chronic type: Acute basilar artery occlusion occurs but does not lead to recanalization, and the vessel remains permanently occluded for more than 3 months.

Posterior circulation strokes account for approximately 15–20% of all ischemic strokes. Basilar artery occlusion (BAO) accounts for only 1–4% of these, but acute and complete BAO leads to high morbidity and mortality (up to 90%) if spontaneous recanalization does not occur 2). Basilar artery stenosis has been reported in approximately 1.43% of patients with acute ischemic stroke 1).

CBAO can cause impairment in both the afferent and efferent visual pathways. Rarely, a single lesion may produce symptoms in both pathways.

Q How does chronic basilar artery occlusion differ from acute basilar artery occlusion?
A

Acute basilar artery occlusion causes severe brainstem ischemia and locked-in syndrome due to underdeveloped collateral circulation, with extremely high mortality. In contrast, chronic occlusion allows sufficient collateral circulation development, resulting in mild symptoms or sometimes asymptomatic presentation.

In basilar artery occlusion, the latency period from initial prodromal symptoms to stroke onset can range from several days to several months. Depending on the location of the brainstem lesion, the following symptoms may occur.

  • Paresthesia: Numbness or abnormal sensations in the limbs.
  • General weakness: Muscle weakness in the limbs.
  • Difficulty walking and unsteadiness: Balance disorders due to cerebellar ischemia.
  • Visual symptoms: Decreased vision, visual field defects, double vision. Transient blurred vision may also occur1).

Clinical Findings (Findings Confirmed by Physician Examination)

Section titled “Clinical Findings (Findings Confirmed by Physician Examination)”

In CBAO, various neuro-ophthalmological findings appear in both efferent and afferent pathways.

Afferent findings

Homonymous hemianopia: Most common visual field defect due to posterior cerebral artery (PCA) lesion. Occipital lobe lesions may show macular sparing and congruous visual field defects.

Cortical visual impairment: Due to bilateral occipital lobe ischemia. Light reflex is preserved but visual acuity is severely reduced.

Homonymous sectoranopia: Occlusion of the anterior or posterior choroidal artery causes a wedge-shaped defect near the horizontal meridian.

Pontine ischemia impairs the horizontal gaze pathway involving the abducens nucleus (CN VI) and the medial longitudinal fasciculus. Vertebrobasilar circulatory disorders are common in ophthalmology and present with various brainstem syndromes depending on the lesion site.

Q What is internuclear ophthalmoplegia (INO)?
A

When the medial longitudinal fasciculus (MLF) in the pons is damaged, adduction of the ipsilateral eye is impaired, and dissociated nystagmus (nystagmus on abduction) appears in the contralateral eye. Bilateral INO strongly suggests a brainstem lesion. For details, see the “Main Symptoms and Clinical Findings” section.

The main causes of basilar artery occlusion are as follows:

  • Atherosclerosis: Most common in the proximal and middle portions of the basilar artery.
  • Thromboembolism: More common than atherosclerosis as a cause of large vessel ischemia in the posterior circulation.
  • Arterial dissection: Vertebral artery dissection can cause basilar artery occlusion.
  • Giant cell arteritis: Rarely affects the vertebral and basilar arteries, causing posterior circulation stroke3).

Treatable vascular risk factors include the following:

  • Hypertension
  • Diabetes mellitus: Poor glycemic control significantly increases risk1)
  • Hyperlipidemia
  • Smoking
  • Obesity
Q Can basilar artery occlusion be prevented?
A

Complete prevention is difficult, but managing vascular risk factors such as treating hypertension, diabetes, and hyperlipidemia, smoking cessation, and maintaining a healthy weight can improve prognosis. For details, see the “Standard Treatment” section.

The diagnosis of basilar artery occlusion involves a combination of multiple imaging tests.

TestFeaturesMain Use
CT + CTAFast, high accuracy, can assess calcification and plaqueInitial test, stenosis evaluation
MRI (DWI)Detects hyperacute ischemic changes as high signalVisualization of acute ischemic infarction
MRANoninvasive, low contrast doseEvaluation of vascular course and stenosis
DSAHighest resolution, excellent for visualizing collateral circulationDetailed evaluation, endovascular treatment

Non-contrast head CT and CT angiography (CTA) are the initial tests for BAO. CTA has high sensitivity for identifying the degree of stenosis and the extent of infarction. Diffusion-weighted MRI (DWI) can detect lesions as hyperintense areas in hyperacute cerebral infarction that are difficult to detect on T2-weighted or FLAIR images.

Combining neck CT or MRI with CTA or MRA can identify not only the occlusion site but also more proximal causative lesions (e.g., vertebral artery dissection). Digital subtraction angiography (DSA) may be required for detailed evaluation of collateral circulation or pre-treatment assessment.

Cortical or brainstem lesions causing efferent or afferent symptoms are considered in the differential diagnosis.

  • Foville syndrome: Ipsilateral facial palsy, contralateral hemiplegia, and ipsilateral gaze palsy due to a lesion in the lower pons.
  • Millard-Gubler syndrome: Ipsilateral facial and abducens nerve palsy, contralateral hemiplegia due to a lesion in the ventral pons.
  • Subarachnoid hemorrhage: A condition with acute headache caused by rupture of a cerebral aneurysm, etc.
  • Intracranial hemorrhage: Acute neurological deficits due to intraparenchymal hemorrhage.

Consensus on the optimal acute management of BAO has not been established, but it is generally treated similarly to other large vessel occlusive diseases.

Rapid stroke evaluation is critical, and aggressive intervention should be considered if within the therapeutic time window.

  • Intravenous thrombolysis (IV t-PA): In Japan, alteplase (Activacin) is administered intravenously at a dose of 0.6 mg/kg within 4.5 hours of onset.
  • Mechanical thrombectomy: If recanalization is not achieved with IV t-PA, endovascular treatment using stent retriever devices is considered. Promising results have been reported in BAO patients within 6 to 24 hours of symptom onset.
  • Intra-arterial thrombolysis (IAT): A meta-analysis of 420 BAO patients showed no difference in outcomes between IAT and IV t-PA.

Some patients with chronic BAO have sufficient collateral circulation to vital structures, and the following secondary prevention is the mainstay of treatment.

  • Antithrombotic therapy: After investigating the embolic source, choose antiplatelet therapy (aspirin, dual therapy, etc.) or anticoagulation therapy. Decide with a multidisciplinary team.
  • Management of vascular risk factors: Treatment of hypertension, diabetes, and hyperlipidemia; maintaining a healthy weight; smoking cessation.
  • Prevention of recurrent cerebral infarction: Administration of antiplatelet drugs (e.g., aspirin) or anticoagulants (e.g., warfarin). In cerebral embolism, a common cause of homonymous hemianopia, searching for embolic sources such as the heart or aorta is important.
Q How soon after onset should treatment be started?
A

Intravenous thrombolysis (t-PA) is indicated within 4.5 hours of onset. Mechanical thrombectomy may be effective within 6 to 24 hours. In any case, prompt consultation and diagnosis greatly influence prognosis.

6. Pathophysiology and Detailed Mechanism of Onset

Section titled “6. Pathophysiology and Detailed Mechanism of Onset”

Anatomy and Vascular Territory of the Basilar Artery

Section titled “Anatomy and Vascular Territory of the Basilar Artery”

The basilar artery begins at the medullopontine junction and ends at the pons-midbrain junction. Anatomically, it is divided into three segments: proximal, middle, and distal, and bifurcates into the left and right posterior cerebral arteries (PCA) as terminal branches.

The posterior cerebral artery is a branch of the basilar artery and supplies the following structures.

  • Midbrain
  • Choroid plexus
  • Posterior thalamus
  • Cortex (deep temporal lobe and occipital lobe)

Blood flow to the visual cortex is mostly supplied by the calcarine artery, a terminal branch of the posterior cerebral artery, but also by the posterior temporal artery and the parieto-occipital artery. Occlusion of the main trunk of the posterior cerebral artery causes homonymous hemianopia and thalamic syndrome with contralateral sensory disturbance, while occlusion of only the calcarine artery results in homonymous hemianopia alone.

Occlusive lesions can occur at any site in the basilar artery. Ischemia most often occurs in the paramedian region of the pontine base, but sometimes extends to the paramedian region of the pontine tegmentum. Atherosclerotic lesions are common in the proximal and middle portions of the basilar artery.

Top of the Basilar Syndrome and Locked-in Syndrome

Section titled “Top of the Basilar Syndrome and Locked-in Syndrome”

Top of the basilar syndrome and thrombus extension are life-threatening. In locked-in syndrome, consciousness is clear, but all voluntary movement is lost, and only vertical eye movements may be preserved.

Collateral Circulation and Chronic Occlusion

Section titled “Collateral Circulation and Chronic Occlusion”

Collateralization is a compensatory mechanism against ischemia. In CBAO, sufficient development of collateral circulation to the PCA is crucial for symptom reduction. Unlike acute occlusion, chronic occlusion may result in mild symptoms due to the development of collateral blood flow.

Even in complete homonymous hemianopia due to occipital lobe lesions, a visual field of approximately 5 to 10 degrees around the center may remain (macular sparing). Causes include dual blood supply to the occipital pole (the calcarine artery, a branch of the posterior cerebral artery, and branches of the middle cerebral artery) and the large cortical area corresponding to the macular visual field.


7. Latest Research and Future Perspectives (Investigational Reports)

Section titled “7. Latest Research and Future Perspectives (Investigational Reports)”

Expanding Indications for Endovascular Treatment

Section titled “Expanding Indications for Endovascular Treatment”

The benefit of endovascular treatment for large vessel occlusion in the anterior circulation is established, but challenges remain for the posterior circulation. Mechanical thrombectomy has shown promising results in BAO patients within 6 to 24 hours of symptom onset, and expansion of the treatment time window is being considered.

Long-term Management of Basilar Artery Stenosis

Section titled “Long-term Management of Basilar Artery Stenosis”

Akram et al. (2025) reported a case of a 76-year-old diabetic patient with basilar artery stenosis, noting that 50% basilar artery stenosis carries a 46% risk of recurrence within 90 days. The SAMMPRIS trial showed that stenting of the basilar artery had a higher perioperative risk compared to medical therapy (20.8% vs 6.7%), indicating that the indication for intracranial stenting should be carefully considered 1).

Giant Cell Arteritis and Posterior Circulation Stroke

Section titled “Giant Cell Arteritis and Posterior Circulation Stroke”

Wong et al. (2022) reported a case in which giant cell arteritis (GCA) caused bilateral vertebral artery thrombosis and posterior circulation stroke. The patient presented with cortical blindness due to bilateral occipital lobe infarction, and diagnosis was confirmed by temporal artery biopsy. Giant cell arteritis should be considered as a rare cause of posterior circulation stroke in the differential diagnosis 3).

Endovascular Treatment for Vertebrobasilar Artery Occlusion

Section titled “Endovascular Treatment for Vertebrobasilar Artery Occlusion”

Costa et al. (2022) reported a case of bilateral vertebral artery occlusion treated with V4 segment stenting, resulting in good recovery. This suggests the efficacy of endovascular treatment for vertebrobasilar artery occlusion refractory to medical therapy 4).


  1. Akram MR, Veena F, Sabah Afroze F, et al. Unmasking the Basilar Culprit: A Case of Acute Posterior Circulation Stroke in a Diabetic Septuagenarian. Cureus 2025;17(3):e79947.
  2. Umalkar GN Jr., Chavan G, Gadkari C, et al. Posterior Circulation Stroke Secondary to Basilar Artery Thrombosis With a Fatal Outcome. Cureus 2023;15(1):e34146.
  3. Wong J, Chan S, Shetty A. A Case of Giant Cell Arteritis Presenting As Catastrophic Posterior Circulation Stroke: A Diagnostic Dilemma. Cureus 2022;14(8):e27961.
  4. Costa A, Miranda O, Cerqueira A, et al. A Patient With (Initially) Non-Persistent Vertigo - A Posterior Circulation Stroke Case. Cureus 2022;14(1):e21468.

Copy the article text and paste it into your preferred AI assistant.